Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | KDM4A | O75164 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 11/20 | 0.41 |
| ▸ | TSPO | P30536 | 1/20 | 0.38 |
| ▸ | IDH1 | O75874 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4291912 | 0.87 | NFKB1 (0.42) | MAPTIDH1MAOBALDH1A1 | |
| SCHEMBL4279412 | 0.85 | MAPT (0.43) | POLBMAPTIDH1MAOAMAOB | |
| SCHEMBL4286495 | 0.84 | IDH1 (0.41) | IDH1MAOBKDM4EALDH1A1 | |
| SCHEMBL4286864 | 0.84 | IDH1 (0.41) | POLBIDH1MAOBALDH1A1 | |
| SCHEMBL4279610 | 0.83 | POLB (0.48) | POLBKDM4AMAPTKDM4CHTR2A | |
| SCHEMBL4279693 | 0.83 | SLC5A1 (0.45) | IDH1MAOAMAOBL3MBTL1KDM4E | |
| SCHEMBL4289375 | 0.82 | HTR2A (0.41) | HTR2AIDH1MAOAMAOBALDH1A1 | |
| SCHEMBL4292523 | 0.81 | PARP10 (0.43) | POLBHTR2AMAOAMAOB | |
| SCHEMBL4279556 | 0.80 | POLB (0.39) | POLBHTR2AMAOBALDH1A1 | |
| SCHEMBL4288111 | 0.79 | IDH1 (0.38) | IDH1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-2048150-A1 | BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | POLB 4872/4885KDM4A 1867/4885MAPT 2884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.